SECTION 1
A 14-year-old girl presented to the neurology clinic complaining of headaches. She described her headaches as mild (intensity 3/10), holocranial, and pounding in character. There was no nausea or vomiting, or photophobia or phonophobia. The patient described in detail a sequence of symptoms from the onset of her headaches. First she experienced "funny vision changes in her right eye" characterized by a very bright spinning colored wheel and scotomas. These visual experiences gave rise to right leg numbness, lasting a total of 45 seconds. Following the leg numbness, only the headache would persist, for no longer than 5 minutes. The patient reported no change in consciousness during these symptoms.
These episodes started 6 months prior to the patient's presentation at the neurology clinic and had progressed with increased frequency from monthly to weekly. In between the episodes, she had no complaints. There was no history of head trauma and the patient's past medical history was unremarkable. Family history was only significant for a maternal cousin with migraines. The patient's general and neurologic examination findings were normal. She was asymptomatic during the examination.
Questions for consideration:
1. What other questions are pertinent for this case? 2. Where would you localize the symptoms?
SECTION 2
We compiled a detailed description of the patient's visual complaints in an attempt to localize her symptoms. Additional questioning revealed that when she closed the right eye she still had visual symptoms in the nasal field of the left eye. Although a right monocular field involvement was initially suspected, these additional details instead suggested a right homonymous hemianopia. The patient's initial description of the headache as holocranial suggested a generalized process; however, the right visual field symptoms and the right leg numbness suggested localization to the left occipital and parietal cortex, respectively.
Questions for consideration:
1. What differential diagnosis would you consider at this time? 2. What diagnostic tests should be ordered at this time?
SECTION 3
The differential diagnosis consideration included paroxysmal episodes affecting the occipital and parietal cortex in a "wave-like" pattern. Migraine with aura and focal seizures were considered in the differential diagnosis.
A routine sleep-deprived EEG was obtained and the results were normal. Due to the focal nature of the patient's prodromal symptoms, a brain MRI was obtained and revealed a lesion in the left occipito-parietal cortex and subcortical white matter with no associated edema or mass effect. Additionally, there were small foci of calcifications and heterogenous contrast enhancement (figure 1). Magnetic resonance angiography results were normal. Although the EEG results were normal, the stereotypical episodes along with the focal radiologic findings favored focal seizures as the most likely diagnosis. Accordingly, antiepileptic medication (levetiracetam 500 mg twice a day) was started with partial response. The MRI findings favored a benign tumor due to the lack of mass effect and presence of calcifications. Low-grade oligodendroglioma and dysembryoplastic neuroepithelial tumor (DNET) were initially considered. However, the heterogenous contrast enhancement raised concern for a more aggressive tumor. A vascular malformation was believed to be less likely due to the normal magnetic resonance angiogram findings.
Two approaches were discussed with the family. The first approach involved follow-up serial imaging to evaluate the rate of progression and consider surgery at a later time. The second approach was surgical resection with intraoperative electrocorticography. The decision was made to pursue the second approach in order to remove the lesion, obtain a tissue diagnosis, and remove the epileptiform cortex. Only partial resection of about 80% of the tumor was possible due to its vicinity to the vein of Labbé.
Preoperative electrocorticography showed frequent spike discharges around the border of the tu- mor (figure 2). Following resection, there were persistent spikes present posteriorly but further resection was not deemed appropriate due to the tumor's proximity to the patient's visual cortex.
Tumor histology revealed meningioangiomatosis of predominant cellular type ( figure 3) . The levetiracetam dose was increased postoperatively due to seizure recurrence up to 1,250 mg twice a day. The patient has remained seizure-free for 3 months. Her ophthalmologic examination results are normal.
DISCUSSION
Our patient was referred to the neurology clinic with a very common complaint: a headache. It is important to consider a broad differential when evaluating patients who present with headaches so that alternative diagnoses requiring different treatment and intervention are not missed. Although our patient's symptoms could have easily fit a classic migraine diagnosis (aura lasting less than 60 minutes followed by a headache), there are important points in her symptoms that guide the clinical reasoning away from the diagnosis of migraine headaches. The International Headache Society classifies migraine headaches with certain characteristics including duration between 4 and 72 hours, associated photophobia or phonophobia, and nausea or vomiting. 1 None of those characteristics were present in this case. It was the lack of typical migraine characteristics that dictated a broader differential for other paroxysmal events. Due to the stereotypic nature of the event, occipital lobe seizures followed by a postictal headache was considered a more likely diagnosis.
Migraine with aura and occipital lobe epilepsy can be difficult to distinguish but elementary visual hallucinations of occipital lobe epilepsy are fundamentally different from the aura of migraine. 2 In migraines the visual aura usually starts as a flickering, uncolored, zigzag line in the center of the visual field. Symptoms gradually progress over 4 -30 minutes and total duration does not exceed 60 minutes. 2 In occipital seizures, the visual hallucinations often appear in the periphery of the visual field and are mainly colored and circular. They develop rapidly within seconds and are brief in duration (2-3 minutes). 2 Postictal headache frequently occurs after the seizure and often generates migraine attacks. A high rate of postictal headache in occipital epilepsy was previously demonstrated.
Although the initial EEG was negative, the presence of a structural abnormality in the brain MRI, along with the elevated clinical suspicion, prompted starting an antiepileptic medication that resulted in improvement in the patient's complaints. Routine EEG often can be normal in occipital lobe epilepsy 2 but electrocorticography showed frequent focal epileptiform discharges.
The tumor biopsy revealed meningioangiomatosis, a rare, benign, hamartomatous focal lesion of leptomeninges and underlying cerebral cortex. 3 Microscopically, this lesion is characterized by leptomeningeal meningothelial and meningovascular proliferation and it can be classified as mainly cellular or vascular. 3, 4 Calcification, gliosis, periventricular connective tissue proliferation, dysplastic neurons, white matter cysts, and large-vessel hyalinization have also been described. 3, 4 Immunostaining has limited diagnostic value. 3 Associated adjacent abnormalities including meningioma 5 and oligodendroglioma 6 have been reported. Meningioangiomatosis is most commonly a sporadic disorder and characteristically presents with refractory localization-related epilepsy but can also present with headache or facial pain, lower cranial nerve palsies, or even be asymptomatic. 3 Meningio- angiomatosis can also be associated with neurofibromatosis type 2, 7 and these patients are usually asymptomatic and have multiple lesions. Lesions in sporadic cases are usually solitary; however, multifocal lesions have also been described. Most lesions are cortical and involve most frequently the frontal and temporal lobes. 3 Extracortical lesions are more common in patients with neurofibromatosis and can include the third ventricle, cerebral peduncle, pulvinar, corpus callosum, trigeminal ganglia, and medulla. 3 Some studies suggest that meningioangiomatosis has predilection for male gender 3 but this is not consistent in other studies. 8 The mean age of presentation is 21 years for patients without neurofibromatosis and 28 years for patients with associated neurofibromatosis. 3 The treatment for meningioangiomatosis is surgical resection and it is curative if a total resection is achieved. 8 Meningioangiomatosis represents about 3% of brain tumors associated with medically intractable epilepsy. 9 In a study of 7 patients with meningioangiomatosis and seizures who underwent tumor resection, seizure-free frequency was seen in 43%, improvement in seizure frequency was seen in 30%, and no improvement in 28%. Review of the literature by the same group showed seizure-free rates of 68%, improvement in seizure frequency in 30%, and no improvement in 5%. In both groups, the majority of patients continued to require antiepileptic medications (71% and 79%). 3 Radiologic characteristics suggestive of meningioangiomatosis include well-demarcated focal lesions that are isointense or hypointense in T1-weighted images, commonly surrounded by an area of increased intensity on T2-weighted images, presence of calcifications, and nonhomogenous contrast enhancement. 3, 8 A presurgical diagnosis remains difficult because the diagnostic tools lack specificity.
MRI findings in meningioangiomatosis may mimic other pathologic processes including meningioma, oligodendroglioma, DNET, and calcified arterial-venous malformation. The need for a correct diagnosis is highlighted because of its benign course and nonrecurrent nature.
This case emphasizes the need to follow the clinical criteria to diagnose migraine headaches to avoid misdiagnosing cases where alternative diagnosis, such as occipital lobe seizures, should be considered.
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